Table 1 Characteristics of randomized controlled trials on acute migraine treatment included in the present study
From: Acute and preventive treatment of menstrual migraine: a meta-analysis
Trial | Treatment | Total n(m;c) | Classified by ICHD criteria? |
|---|---|---|---|
Mannix2007(MM1) [11]a | Rizatriptan10mg | 357(234;157) | Yes |
Mannix2007(MM2) [11]a | Rizatriptan10mg | 348(245;103) | Yes |
Martin2007(TAME1) [12]a | Rizatriptan10mg | 43(34;9) | Yes |
Martin2007(TAME2) [12]a | Rizatriptan10mg | 51(29;22) | Yes |
Silberstein2000 [13]a | Rizatriptan5mg,10 mg | 910(534;376) | Yes |
Landy2004(SUM40282) [14] | Sumatriptan50mg,100 mg | 265(133;132) | No |
Landy2004(SUM40285) [14] | Sumatriptan50mg,100 mg | 233(115;118) | No |
Dowson2005 [15] | Sumatriptan100mg | 78(39;39) | No |
Cady2011(NCT00329355) [16] | Sumatriptan85mg + Naproxen500mg | 262(124;138) | Yes |
Cady2011(NCT00329355) [16] | Sumatriptan85mg + Naproxen500mg | 252(124;128) | Yes |
Tuchman2006 [17] | Zolmitriptan2.5 mg | 334(174;160) | No |
Massiou2005 [18] | Naratriptan2.5 mg | 229(115;114) | No |
Diamond2008 [19]a | Almotriptan12.5 mg | 42(20;22) | No |
Allais2010 [20] | Almotriptan12.5 mg | 244(122;122) | No |
Allais2006 [21] | Almotriptan12.5 mg vs. Zolmitriptan2.5 mg | 255(Almotriptan136;Zolmitriptan119) | No |
Allais2011 [22] | Frovatriptan2.5 mg vs. Zolmitriptan2.5 mg | 138(Frovatriptan73;Zolmitriptan65) | Yes |
Bartolini2012 [23] | Frovatriptan2.5 mg vs. Almotriptan12.5 mg | 148(Frovatriptan79;Almotriptan79) | No |
Savi2011 [24] | Frovatriptan2.5 mg vs. Rizatriptan10mg | 107(Frovatriptan48;Rizatriptan59) | No |
Macgrogor2022 [25]a | Lasmiditan100mg | 169(90;79) | Yes |
Silberstein1999 [26] | AAC(acetaminophen250mg + caffeine85mg + acetylsalicylic acid250mg) | 180(85; 100) | No |